Phase 1 Study of CM082 (X-82) Tablets in Advanced Cancer Patients in China

Clinical trial NCT01863485 · COMPLETED

Trial details

NCT number: NCT01863485
Sponsor: AnewPharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2013-05-01
Primary completion: 2014-10-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.